Loading...
XASE
ELMD
Market cap231mUSD
Dec 05, Last price  
27.81USD
1D
0.04%
1Q
13.65%
Jan 2017
616.75%
IPO
631.84%
Name

Electromed Inc

Chart & Performance

D1W1MN
XASE:ELMD chart
P/E
30.78
P/S
3.62
EPS
0.90
Div Yield, %
Shrs. gr., 5y
-0.24%
Rev. gr., 5y
14.53%
Revenues
64m
+16.97%
8,752,12912,998,62714,303,84819,003,50719,524,48915,104,42215,487,87519,408,38522,991,99925,861,14428,697,62231,299,75032,470,68835,756,00041,659,00048,067,00054,716,00064,000,000
Net income
8m
+46.35%
267,8521,332,906916,3381,055,577186,606-1,329,276-1,288,5941,092,4862,212,5022,229,4721,902,3961,969,2184,161,0002,362,0002,305,0003,166,0005,150,0007,537,000
CFO
11m
+25.65%
243,158-1,157,706607,937-1,415,104-1,171,7771,876,6572,062,6612,781,2142,166,9031,191,1212,442,2002,589,8744,196,4483,077,000-686,0001,315,0009,067,00011,393,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
IPO date
Aug 13, 2010
Employees
170
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT